SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-345018
Filing Date
2018-12-07
Accepted
2018-12-07 17:02:01
Documents
4
Effectiveness Date
2018-12-07

Document Format Files

Seq Description Document Type Size
1 S-8 d668756ds8.htm S-8 81729
2 EX-5.1 d668756dex51.htm EX-5.1 5762
3 EX-23.2 d668756dex232.htm EX-23.2 1444
4 GRAPHIC g668756g52p22.jpg GRAPHIC 4684
  Complete submission text file 0001193125-18-345018.txt   96834
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-228719 | Film No.: 181224120
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1